InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: biowreck post# 172545

Wednesday, 01/16/2019 9:34:04 AM

Wednesday, January 16, 2019 9:34:04 AM

Post# of 425918
bwreck...

Quote: "Des market has plenty of competitors already. I’ve been on V for years now...and guess what...I still got Des."

I was a long term sufferer of DES. I had little eye drop bottles all over my house and office and since I was a surgeon it was more than an inconvenience because I had to interrupt my surgeries to put drops in because none of them lasted more than a half an hour...

Competitors???

Allergan makes Restasis eyedrops...which cost about $1,500/month and....

https://jamanetwork.com/journals/jamainternalmedicine/article-
abstract/2666792

"But the more fundamental question has received little attention: does Restasis work? Restasis is not approved in the European Union, Australia, or New Zealand, where in 2001 registration applications were “withdrawn prior to approval due to insufficient evidence of efficacy.”1 Although Canada approved Restasis,2 its national health technology assessment unit, unconvinced of meaningful benefit, recommended Canada not pay for it."

I can not speak for your situation and have only your word for it..but V at 4gms/day...Completely relieved my dry eye syndrome....

Don't try so hard To eviscerate Vascepa...Your comments and disappointment with the drug are inconsistent with someone who is long the stock or is taking Vascepa...

":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News